These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19497084)

  • 1. Too much ado about instrumental variable approach: is the cure worse than the disease?
    Baser O
    Value Health; 2009; 12(8):1201-9. PubMed ID: 19497084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
    Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
    Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication.
    Fang G; Brooks JM; Chrischilles EA
    Am J Epidemiol; 2012 Jun; 175(11):1142-51. PubMed ID: 22510277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Too much ado about propensity score models? Comparing methods of propensity score matching.
    Baser O
    Value Health; 2006; 9(6):377-85. PubMed ID: 17076868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of physician economic incentives on admission rates of patients with ambulatory sensitive conditions: an analysis comparing two managed care structures and indemnity insurance.
    Josephson GW; Karcz A
    Am J Manag Care; 1997 Jan; 3(1):49-56. PubMed ID: 10169249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does competition by health maintenance organizations affect the adoption of cost-containment measures by fee-for-service plans?
    Joesch JM; Wickizer TM; Feldstein PJ
    Am J Manag Care; 1998 Jun; 4(6):832-8. PubMed ID: 10181069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instruments for causal inference: an epidemiologist's dream?
    Hernán MA; Robins JM
    Epidemiology; 2006 Jul; 17(4):360-72. PubMed ID: 16755261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.
    Kaskie B; Wallace N; Kang S; Bloom J
    J Ment Health Policy Econ; 2006 Mar; 9(1):15-24. PubMed ID: 16733268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the effect of treatment rate changes when treatment benefits are heterogeneous: antibiotics and otitis media.
    Park TR; Brooks JM; Chrischilles EA; Bergus G
    Value Health; 2008; 11(2):304-14. PubMed ID: 18380643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing causal treatment effect estimation when using large observational datasets.
    John ER; Abrams KR; Brightling CE; Sheehan NA
    BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size importantly limits the usefulness of instrumental variable methods, depending on instrument strength and level of confounding.
    Boef AG; Dekkers OM; Vandenbroucke JP; le Cessie S
    J Clin Epidemiol; 2014 Nov; 67(11):1258-64. PubMed ID: 25124167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some cautions on the use of instrumental variables estimators in outcomes research: how bias in instrumental variables estimators is affected by instrument strength, instrument contamination, and sample size.
    Crown WH; Henk HJ; Vanness DJ
    Value Health; 2011 Dec; 14(8):1078-84. PubMed ID: 22152177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.
    Hadley J; Polsky D; Mandelblatt JS; Mitchell JM; Weeks JC; Wang Q; Hwang YT;
    Health Econ; 2003 Mar; 12(3):171-86. PubMed ID: 12605463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
    Sullivan SD; Lee TA; Blough DK; Finkelstein JA; Lozano P; Inui TS; Fuhlbrigge AL; Carey VJ; Wagner E; Weiss KB
    Arch Pediatr Adolesc Med; 2005 May; 159(5):428-34. PubMed ID: 15867115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
    Meyers J; Yu Y; Kaye JA; Davis KL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-service outcomes data and its effect on asthma treatment: a salmeterol pilot investigation.
    Bukstein D; Mackowiak J
    Med Interface; 1997 Feb; 10(2):118-24. PubMed ID: 10164788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.